Public-registry site landscape for NCT05065411, a Metastatic Breast Cancer study sponsored by Veru Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05065411 (registry record) |
| Sponsor | Veru Inc. |
| Condition(s) | Metastatic Breast Cancer |
| Phase | PHASE3 |
| Listed sites | 30 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05065411 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →